Share Price and Basic Stock Data
Last Updated: January 9, 2026, 5:42 pm
| PEG Ratio | -1.71 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Deccan Cements Ltd operates in the cement industry and has exhibited fluctuating revenue performance over recent quarters. The company reported sales of ₹180.46 Cr in September 2022, which increased to ₹211.13 Cr by December 2022. However, sales experienced a decline to ₹167.25 Cr in September 2023 before recovering to ₹216.86 Cr in December 2023. Annual sales figures showed a slight dip, standing at ₹782 Cr for FY 2023, compared to ₹792 Cr in FY 2022. The TTM sales were reported at ₹525 Cr, indicating a decline against the previous fiscal year. This trend suggests a volatile market environment, potentially influenced by demand fluctuations and operational challenges. The company’s operating profit margin (OPM) was recorded at 14.37%, indicating a moderate level of efficiency in generating profit relative to sales. These revenue dynamics reflect the competitive landscape of the cement industry, where companies are often challenged by input cost volatility and demand variability, which are critical for sustaining growth.
Profitability and Efficiency Metrics
Profitability metrics for Deccan Cements reveal a mixed performance. The net profit for the quarter ending September 2023 stood at ₹4.73 Cr, a significant decrease from ₹14.14 Cr in June 2023. The net profit margin for FY 2025 is projected to be low at 1.42%, reflecting pressures on profitability. The company’s return on equity (ROE) was reported at 0.75%, and the return on capital employed (ROCE) was a mere 1.53%, both indicating subpar returns compared to industry standards. The interest coverage ratio (ICR) is relatively strong at 4.04x, suggesting that Deccan Cements can comfortably meet its interest obligations. However, the cash conversion cycle (CCC) stood at 386 days, indicating inefficiencies in working capital management, which could hinder liquidity. While the company has managed to maintain an OPM of 14.37%, the declining profitability and efficiency ratios highlight areas that require urgent attention to enhance overall financial health.
Balance Sheet Strength and Financial Ratios
The balance sheet of Deccan Cements Ltd shows a concerning trend in leverage and asset management. Total borrowings increased to ₹760 Cr, while reserves stood at ₹739 Cr, indicating a precarious balance between debt and equity. The debt-to-equity ratio of 0.98x suggests that the company is nearly at a 1:1 ratio of debt to equity, which could pose risks in times of financial strain. The current ratio was reported at 1.17x, indicating a reasonable liquidity position, while the quick ratio of 0.82x suggests potential challenges in meeting short-term liabilities without selling inventory. The price-to-book value ratio (P/BV) stood at 1.52x, which is relatively healthy in comparison to industry norms. However, the declining return on assets (ROA) at 0.46% points to inefficiencies in utilizing assets to generate earnings. Overall, while the company maintains a balanced approach to its capital structure, the high levels of borrowing may expose it to financial risks if market conditions worsen.
Shareholding Pattern and Investor Confidence
Deccan Cements Ltd’s shareholding pattern reflects a stable yet concentrated ownership structure. The promoters hold 56.24% of the company, which indicates a strong commitment from the founding members. Foreign Institutional Investors (FIIs) have increased their stake from 8.97% in December 2022 to 9.93% by September 2025, suggesting a growing interest from international investors. Domestic Institutional Investors (DIIs) hold a minor stake of 0.90%, while public shareholding stands at 32.92%. The total number of shareholders has decreased from 17,605 in December 2022 to 11,952 by September 2025, indicating potential concerns about market confidence. The dividend payout ratio is relatively high at 55.89%, which may appeal to income-focused investors despite the low profitability metrics. The concentrated promoter holding coupled with a rising FII stake reflects a mixed sentiment among investors, balancing confidence in management with concerns over financial performance.
Outlook, Risks, and Final Insight
Looking ahead, Deccan Cements Ltd faces several challenges and opportunities. The company’s ability to enhance profitability metrics and manage its high debt levels will be crucial for future growth. Risks include the volatility in cement prices, potential increases in operational costs, and the looming threat of economic downturns that could impact construction demand. On the positive side, the company’s strong promoter backing and improved interest coverage position provide a buffer against short-term financial strains. The focus on operational efficiency and potential expansion in market share through strategic initiatives could bolster revenue streams. If Deccan Cements successfully addresses its working capital inefficiencies and stabilizes its profit margins, it may enhance investor confidence and pave the way for a more robust financial outlook. However, without significant improvements in profitability and efficiency metrics, the company may struggle to sustain its market position in a competitive landscape.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Bheema Cements Ltd | 52.7 Cr. | 16.2 | 19.5/16.2 | 0.60 | 0.00 % | 13.1 % | 108 % | 10.0 | |
| UltraTech Cement Ltd | 3,55,501 Cr. | 12,064 | 13,102/10,048 | 48.5 | 2,444 | 0.64 % | 10.9 % | 9.29 % | 10.0 |
| The Ramco Cements Ltd | 25,579 Cr. | 1,082 | 1,209/788 | 133 | 322 | 0.18 % | 4.83 % | 1.56 % | 1.00 |
| The India Cements Ltd | 14,757 Cr. | 476 | 486/239 | 325 | 0.00 % | 5.49 % | 8.83 % | 10.0 | |
| Star Cement Ltd | 8,965 Cr. | 222 | 309/196 | 29.6 | 74.4 | 0.45 % | 8.39 % | 6.05 % | 1.00 |
| Industry Average | 37,839.00 Cr | 1,928.14 | 37.34 | 573.47 | 0.54% | 8.79% | 85.81% | 7.13 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 180.46 | 211.13 | 195.94 | 192.08 | 167.25 | 216.86 | 223.24 | 172.15 | 120.46 | 115.45 | 118.92 | 150.56 | 140.31 |
| Expenses | 163.64 | 186.08 | 175.42 | 166.86 | 153.55 | 188.28 | 196.93 | 160.83 | 118.27 | 106.70 | 105.80 | 122.68 | 120.15 |
| Operating Profit | 16.82 | 25.05 | 20.52 | 25.22 | 13.70 | 28.58 | 26.31 | 11.32 | 2.19 | 8.75 | 13.12 | 27.88 | 20.16 |
| OPM % | 9.32% | 11.86% | 10.47% | 13.13% | 8.19% | 13.18% | 11.79% | 6.58% | 1.82% | 7.58% | 11.03% | 18.52% | 14.37% |
| Other Income | 1.74 | 1.68 | 3.14 | 3.15 | 3.67 | 4.28 | -11.43 | 3.02 | 2.89 | 3.31 | 6.98 | 2.74 | 2.32 |
| Interest | 2.71 | 3.30 | 3.50 | 2.42 | 2.86 | 3.83 | 3.27 | 3.02 | 3.41 | 3.51 | 2.81 | 3.47 | 3.27 |
| Depreciation | 6.90 | 6.89 | 6.78 | 6.81 | 6.92 | 6.96 | 6.94 | 7.01 | 7.11 | 7.07 | 6.89 | 6.68 | 6.74 |
| Profit before tax | 8.95 | 16.54 | 13.38 | 19.14 | 7.59 | 22.07 | 4.67 | 4.31 | -5.44 | 1.48 | 10.40 | 20.47 | 12.47 |
| Tax % | 26.59% | 26.48% | 26.08% | 26.12% | 37.55% | 30.31% | 35.76% | 34.80% | -25.92% | 45.27% | 23.65% | 24.96% | 27.19% |
| Net Profit | 6.57 | 12.16 | 9.90 | 14.14 | 4.73 | 15.39 | 3.01 | 2.81 | -4.04 | 0.81 | 7.95 | 15.35 | 9.07 |
| EPS in Rs | 4.69 | 8.68 | 7.07 | 10.09 | 3.38 | 10.99 | 2.15 | 2.01 | -2.88 | 0.58 | 5.68 | 10.96 | 6.48 |
Last Updated: January 1, 2026, 11:32 pm
Below is a detailed analysis of the quarterly data for Deccan Cements Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 140.31 Cr.. The value appears to be declining and may need further review. It has decreased from 150.56 Cr. (Jun 2025) to 140.31 Cr., marking a decrease of 10.25 Cr..
- For Expenses, as of Sep 2025, the value is 120.15 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 122.68 Cr. (Jun 2025) to 120.15 Cr., marking a decrease of 2.53 Cr..
- For Operating Profit, as of Sep 2025, the value is 20.16 Cr.. The value appears to be declining and may need further review. It has decreased from 27.88 Cr. (Jun 2025) to 20.16 Cr., marking a decrease of 7.72 Cr..
- For OPM %, as of Sep 2025, the value is 14.37%. The value appears to be declining and may need further review. It has decreased from 18.52% (Jun 2025) to 14.37%, marking a decrease of 4.15%.
- For Other Income, as of Sep 2025, the value is 2.32 Cr.. The value appears to be declining and may need further review. It has decreased from 2.74 Cr. (Jun 2025) to 2.32 Cr., marking a decrease of 0.42 Cr..
- For Interest, as of Sep 2025, the value is 3.27 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 3.47 Cr. (Jun 2025) to 3.27 Cr., marking a decrease of 0.20 Cr..
- For Depreciation, as of Sep 2025, the value is 6.74 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 6.68 Cr. (Jun 2025) to 6.74 Cr., marking an increase of 0.06 Cr..
- For Profit before tax, as of Sep 2025, the value is 12.47 Cr.. The value appears to be declining and may need further review. It has decreased from 20.47 Cr. (Jun 2025) to 12.47 Cr., marking a decrease of 8.00 Cr..
- For Tax %, as of Sep 2025, the value is 27.19%. The value appears to be increasing, which may not be favorable. It has increased from 24.96% (Jun 2025) to 27.19%, marking an increase of 2.23%.
- For Net Profit, as of Sep 2025, the value is 9.07 Cr.. The value appears to be declining and may need further review. It has decreased from 15.35 Cr. (Jun 2025) to 9.07 Cr., marking a decrease of 6.28 Cr..
- For EPS in Rs, as of Sep 2025, the value is 6.48. The value appears to be declining and may need further review. It has decreased from 10.96 (Jun 2025) to 6.48, marking a decrease of 4.48.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:27 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 441 | 407 | 625 | 496 | 570 | 651 | 555 | 758 | 792 | 782 | 799 | 527 | 525 |
| Expenses | 383 | 343 | 511 | 396 | 484 | 556 | 477 | 582 | 630 | 684 | 704 | 492 | 455 |
| Operating Profit | 57 | 64 | 115 | 100 | 86 | 95 | 79 | 176 | 162 | 97 | 96 | 35 | 70 |
| OPM % | 13% | 16% | 18% | 20% | 15% | 15% | 14% | 23% | 20% | 12% | 12% | 7% | 13% |
| Other Income | 2 | 3 | 1 | 2 | 3 | 10 | -0 | 10 | -8 | 9 | -2 | 16 | 15 |
| Interest | 27 | 27 | 15 | 7 | 6 | 8 | 7 | 8 | 10 | 13 | 13 | 13 | 13 |
| Depreciation | 24 | 19 | 20 | 22 | 23 | 22 | 21 | 23 | 26 | 27 | 28 | 28 | 27 |
| Profit before tax | 7 | 21 | 81 | 74 | 61 | 75 | 51 | 155 | 117 | 67 | 53 | 11 | 45 |
| Tax % | 33% | 6% | 43% | 36% | 37% | 39% | -12% | 26% | 25% | 26% | 30% | 30% | |
| Net Profit | 5 | 20 | 46 | 47 | 39 | 46 | 57 | 115 | 88 | 49 | 37 | 8 | 33 |
| EPS in Rs | 3.59 | 14.20 | 32.54 | 33.48 | 27.52 | 32.88 | 40.44 | 82.19 | 62.52 | 35.20 | 26.60 | 5.38 | 23.70 |
| Dividend Payout % | 17% | 9% | 8% | 9% | 11% | 11% | 10% | 6% | 8% | 11% | 11% | 11% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 300.00% | 130.00% | 2.17% | -17.02% | 17.95% | 23.91% | 101.75% | -23.48% | -44.32% | -24.49% | -78.38% |
| Change in YoY Net Profit Growth (%) | 0.00% | -170.00% | -127.83% | -19.20% | 34.97% | 5.96% | 77.84% | -125.23% | -20.84% | 19.83% | -53.89% |
Deccan Cements Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 3% |
| 5 Years: | -1% |
| 3 Years: | -13% |
| TTM: | -35% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -9% |
| 5 Years: | -35% |
| 3 Years: | -58% |
| TTM: | -51% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 31% |
| 3 Years: | 28% |
| 1 Year: | 71% |
| Return on Equity | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 10% |
| 3 Years: | 5% |
| Last Year: | 1% |
Last Updated: September 5, 2025, 2:45 am
Balance Sheet
Last Updated: December 4, 2025, 1:09 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 |
| Reserves | 223 | 238 | 279 | 325 | 358 | 399 | 443 | 558 | 639 | 680 | 712 | 715 | 739 |
| Borrowings | 239 | 191 | 79 | 70 | 33 | 54 | 106 | 104 | 166 | 265 | 520 | 714 | 760 |
| Other Liabilities | 119 | 114 | 127 | 132 | 161 | 161 | 155 | 193 | 173 | 202 | 207 | 189 | 194 |
| Total Liabilities | 588 | 550 | 493 | 535 | 560 | 621 | 710 | 861 | 985 | 1,155 | 1,446 | 1,625 | 1,700 |
| Fixed Assets | 373 | 356 | 342 | 377 | 363 | 354 | 378 | 446 | 453 | 440 | 423 | 402 | 389 |
| CWIP | 35 | 33 | 34 | 0 | 4 | 9 | 62 | 12 | 21 | 241 | 514 | 805 | 895 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 180 | 161 | 116 | 157 | 192 | 258 | 271 | 404 | 511 | 474 | 509 | 417 | 416 |
| Total Assets | 588 | 550 | 493 | 535 | 560 | 621 | 710 | 861 | 985 | 1,155 | 1,446 | 1,625 | 1,700 |
Below is a detailed analysis of the balance sheet data for Deccan Cements Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 7.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 7.00 Cr..
- For Reserves, as of Sep 2025, the value is 739.00 Cr.. The value appears strong and on an upward trend. It has increased from 715.00 Cr. (Mar 2025) to 739.00 Cr., marking an increase of 24.00 Cr..
- For Borrowings, as of Sep 2025, the value is 760.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 714.00 Cr. (Mar 2025) to 760.00 Cr., marking an increase of 46.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 194.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 189.00 Cr. (Mar 2025) to 194.00 Cr., marking an increase of 5.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 1,700.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,625.00 Cr. (Mar 2025) to 1,700.00 Cr., marking an increase of 75.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 389.00 Cr.. The value appears to be declining and may need further review. It has decreased from 402.00 Cr. (Mar 2025) to 389.00 Cr., marking a decrease of 13.00 Cr..
- For CWIP, as of Sep 2025, the value is 895.00 Cr.. The value appears strong and on an upward trend. It has increased from 805.00 Cr. (Mar 2025) to 895.00 Cr., marking an increase of 90.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 416.00 Cr.. The value appears to be declining and may need further review. It has decreased from 417.00 Cr. (Mar 2025) to 416.00 Cr., marking a decrease of 1.00 Cr..
- For Total Assets, as of Sep 2025, the value is 1,700.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,625.00 Cr. (Mar 2025) to 1,700.00 Cr., marking an increase of 75.00 Cr..
However, the Borrowings (760.00 Cr.) are higher than the Reserves (739.00 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -182.00 | -127.00 | 36.00 | 30.00 | 53.00 | 41.00 | -27.00 | 72.00 | -4.00 | -168.00 | -424.00 | -679.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 22 | 27 | 5 | 8 | 9 | 9 | 31 | 12 | 11 | 13 | 25 | 40 |
| Inventory Days | 935 | 712 | 397 | 464 | 364 | 374 | 493 | 341 | 349 | 601 | 408 | 541 |
| Days Payable | 164 | 152 | 150 | 25 | 16 | 27 | 169 | 218 | 132 | 291 | 164 | 194 |
| Cash Conversion Cycle | 793 | 587 | 251 | 446 | 357 | 356 | 355 | 135 | 227 | 323 | 268 | 386 |
| Working Capital Days | 27 | 15 | -2 | 3 | 22 | 10 | 1 | -34 | -51 | -32 | -45 | -65 |
| ROCE % | 7% | 11% | 24% | 21% | 17% | 19% | 13% | 27% | 20% | 9% | 8% | 2% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 |
|---|---|
| FaceValue | 5.00 |
| Basic EPS (Rs.) | 5.37 |
| Diluted EPS (Rs.) | 5.37 |
| Cash EPS (Rs.) | 25.41 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 515.74 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 515.74 |
| Revenue From Operations / Share (Rs.) | 376.21 |
| PBDIT / Share (Rs.) | 36.81 |
| PBIT / Share (Rs.) | 16.77 |
| PBT / Share (Rs.) | 7.67 |
| Net Profit / Share (Rs.) | 5.37 |
| NP After MI And SOA / Share (Rs.) | 5.37 |
| PBDIT Margin (%) | 9.78 |
| PBIT Margin (%) | 4.45 |
| PBT Margin (%) | 2.03 |
| Net Profit Margin (%) | 1.42 |
| NP After MI And SOA Margin (%) | 1.42 |
| Return on Networth / Equity (%) | 1.04 |
| Return on Capital Employeed (%) | 1.76 |
| Return On Assets (%) | 0.46 |
| Long Term Debt / Equity (X) | 0.75 |
| Total Debt / Equity (X) | 0.98 |
| Current Ratio (X) | 1.17 |
| Quick Ratio (X) | 0.82 |
| Dividend Payout Ratio (NP) (%) | 55.89 |
| Dividend Payout Ratio (CP) (%) | 11.80 |
| Earning Retention Ratio (%) | 44.11 |
| Cash Earning Retention Ratio (%) | 88.20 |
| Interest Coverage Ratio (X) | 4.04 |
| Interest Coverage Ratio (Post Tax) (X) | 1.59 |
| Enterprise Value (Cr.) | 1670.92 |
| EV / Net Operating Revenue (X) | 3.17 |
| EV / EBITDA (X) | 32.40 |
| MarketCap / Net Operating Revenue (X) | 2.09 |
| Retention Ratios (%) | 44.10 |
| Price / BV (X) | 1.52 |
| Price / Net Operating Revenue (X) | 2.09 |
| EarningsYield | 0.01 |
After reviewing the key financial ratios for Deccan Cements Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 5.00. This value is within the healthy range. No previous period data is available for comparison.
- For Basic EPS (Rs.), as of Mar 25, the value is 5.37. This value is within the healthy range. No previous period data is available for comparison.
- For Diluted EPS (Rs.), as of Mar 25, the value is 5.37. This value is within the healthy range. No previous period data is available for comparison.
- For Cash EPS (Rs.), as of Mar 25, the value is 25.41. This value is within the healthy range. No previous period data is available for comparison.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 515.74. No previous period data is available for comparison.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 515.74. No previous period data is available for comparison.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 376.21. No previous period data is available for comparison.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 36.81. This value is within the healthy range. No previous period data is available for comparison.
- For PBIT / Share (Rs.), as of Mar 25, the value is 16.77. This value is within the healthy range. No previous period data is available for comparison.
- For PBT / Share (Rs.), as of Mar 25, the value is 7.67. This value is within the healthy range. No previous period data is available for comparison.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 5.37. This value is within the healthy range. No previous period data is available for comparison.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 5.37. This value is within the healthy range. No previous period data is available for comparison.
- For PBDIT Margin (%), as of Mar 25, the value is 9.78. This value is below the healthy minimum of 10. No previous period data is available for comparison.
- For PBIT Margin (%), as of Mar 25, the value is 4.45. This value is below the healthy minimum of 10. No previous period data is available for comparison.
- For PBT Margin (%), as of Mar 25, the value is 2.03. This value is below the healthy minimum of 10. No previous period data is available for comparison.
- For Net Profit Margin (%), as of Mar 25, the value is 1.42. This value is below the healthy minimum of 5. No previous period data is available for comparison.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 1.42. This value is below the healthy minimum of 8. No previous period data is available for comparison.
- For Return on Networth / Equity (%), as of Mar 25, the value is 1.04. This value is below the healthy minimum of 15. No previous period data is available for comparison.
- For Return on Capital Employeed (%), as of Mar 25, the value is 1.76. This value is below the healthy minimum of 10. No previous period data is available for comparison.
- For Return On Assets (%), as of Mar 25, the value is 0.46. This value is below the healthy minimum of 5. No previous period data is available for comparison.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.75. This value is within the healthy range. No previous period data is available for comparison.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.98. This value is within the healthy range. No previous period data is available for comparison.
- For Current Ratio (X), as of Mar 25, the value is 1.17. This value is below the healthy minimum of 1.5. No previous period data is available for comparison.
- For Quick Ratio (X), as of Mar 25, the value is 0.82. This value is below the healthy minimum of 1. No previous period data is available for comparison.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 55.89. This value exceeds the healthy maximum of 50. No previous period data is available for comparison.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 11.80. This value is below the healthy minimum of 20. No previous period data is available for comparison.
- For Earning Retention Ratio (%), as of Mar 25, the value is 44.11. This value is within the healthy range. No previous period data is available for comparison.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 88.20. This value exceeds the healthy maximum of 70. No previous period data is available for comparison.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 4.04. This value is within the healthy range. No previous period data is available for comparison.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.59. This value is below the healthy minimum of 3. No previous period data is available for comparison.
- For Enterprise Value (Cr.), as of Mar 25, the value is 1,670.92. No previous period data is available for comparison.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 3.17. This value exceeds the healthy maximum of 3. No previous period data is available for comparison.
- For EV / EBITDA (X), as of Mar 25, the value is 32.40. This value exceeds the healthy maximum of 15. No previous period data is available for comparison.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.09. This value is within the healthy range. No previous period data is available for comparison.
- For Retention Ratios (%), as of Mar 25, the value is 44.10. This value is within the healthy range. No previous period data is available for comparison.
- For Price / BV (X), as of Mar 25, the value is 1.52. This value is within the healthy range. No previous period data is available for comparison.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.09. This value is within the healthy range. No previous period data is available for comparison.
- For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. No previous period data is available for comparison.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Deccan Cements Ltd:
- Net Profit Margin: 1.42%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 1.76% (Industry Average ROCE: 8.79%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 1.04% (Industry Average ROE: 85.81%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 1.59
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.82
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 30.1 (Industry average Stock P/E: 37.34)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.98
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 1.42%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Cement | Deccan Chambers, Hyderabad Telangana 500082 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Ms. P Parvathi | Chairperson & Managing Director |
| Mr. S Venkateswarlu | Whole Time Director |
| Mrs. Mahpara Ali | Director |
| Mr. Paturi Srinivasa Rao | Director |
| Mr. Srivari Chandrasekhar | Director |
| Mr. Rabindra Srikantan | Director |
FAQ
What is the intrinsic value of Deccan Cements Ltd?
Deccan Cements Ltd's intrinsic value (as of 09 January 2026) is ₹96.34 which is 86.47% lower the current market price of ₹712.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹999 Cr. market cap, FY2025-2026 high/low of ₹1,184/575, reserves of ₹739 Cr, and liabilities of ₹1,700 Cr.
What is the Market Cap of Deccan Cements Ltd?
The Market Cap of Deccan Cements Ltd is 999 Cr..
What is the current Stock Price of Deccan Cements Ltd as on 09 January 2026?
The current stock price of Deccan Cements Ltd as on 09 January 2026 is ₹712.
What is the High / Low of Deccan Cements Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Deccan Cements Ltd stocks is ₹1,184/575.
What is the Stock P/E of Deccan Cements Ltd?
The Stock P/E of Deccan Cements Ltd is 30.1.
What is the Book Value of Deccan Cements Ltd?
The Book Value of Deccan Cements Ltd is 533.
What is the Dividend Yield of Deccan Cements Ltd?
The Dividend Yield of Deccan Cements Ltd is 0.08 %.
What is the ROCE of Deccan Cements Ltd?
The ROCE of Deccan Cements Ltd is 1.53 %.
What is the ROE of Deccan Cements Ltd?
The ROE of Deccan Cements Ltd is 0.75 %.
What is the Face Value of Deccan Cements Ltd?
The Face Value of Deccan Cements Ltd is 5.00.